• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖成人中用于万古霉素AUC估算的峰浓度测量可提高精度并降低偏差。

Peak Measurement for Vancomycin AUC Estimation in Obese Adults Improves Precision and Lowers Bias.

作者信息

Pai Manjunath P, Hong Joseph, Krop Lynne

机构信息

Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA

Morton Plant Hospital, BayCare Health System, Clearwater, Florida, USA.

出版信息

Antimicrob Agents Chemother. 2017 Mar 24;61(4). doi: 10.1128/AAC.02490-16. Print 2017 Apr.

DOI:10.1128/AAC.02490-16
PMID:28096158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5365684/
Abstract

Vancomycin area under the curve (AUC) estimates may be skewed in obese adults due to weight-dependent pharmacokinetic parameters. We demonstrate that peak and trough measurements reduce bias and improve the precision of vancomycin AUC estimates in obese adults ( = 75) and validate this in an independent cohort ( = 31). The precision and mean percent bias of Bayesian vancomycin AUC estimates are comparable between covariate-dependent ( = 0.774, 3.55%) and covariate-independent ( = 0.804, 3.28%) models when peaks and troughs are measured but not when measurements are restricted to troughs only ( = 0.557, 15.5%).

摘要

由于药代动力学参数依赖于体重,肥胖成年人的万古霉素曲线下面积(AUC)估计值可能会有偏差。我们证明,在肥胖成年人(n = 75)中,峰浓度和谷浓度测量可减少偏差并提高万古霉素AUC估计的精度,并在一个独立队列(n = 31)中进行了验证。当测量峰浓度和谷浓度时,贝叶斯万古霉素AUC估计值的精度和平均偏差百分比在依赖协变量(n = 0.774,3.55%)和不依赖协变量(n = 0.804,3.28%)的模型之间具有可比性,但仅测量谷浓度时则不然(n = 0.557,15.5%)。

相似文献

1
Peak Measurement for Vancomycin AUC Estimation in Obese Adults Improves Precision and Lowers Bias.肥胖成人中用于万古霉素AUC估算的峰浓度测量可提高精度并降低偏差。
Antimicrob Agents Chemother. 2017 Mar 24;61(4). doi: 10.1128/AAC.02490-16. Print 2017 Apr.
2
Pilot Study of a Bayesian Approach To Estimate Vancomycin Exposure in Obese Patients with Limited Pharmacokinetic Sampling.一种贝叶斯方法用于在药代动力学采样有限的肥胖患者中估算万古霉素暴露量的初步研究。
Antimicrob Agents Chemother. 2017 Apr 24;61(5). doi: 10.1128/AAC.02478-16. Print 2017 May.
3
Vancomycin area under the curves estimated with pharmacokinetic equations using trough-only data.根据仅使用谷浓度数据的药代动力学方程估算的万古霉素曲线下面积。
J Clin Pharm Ther. 2021 Oct;46(5):1426-1432. doi: 10.1111/jcpt.13474. Epub 2021 Jun 25.
4
Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.万古霉素在疑似或确诊金黄色葡萄球菌感染的极度肥胖患者中的药代动力学。
Pharmacotherapy. 2015 Feb;35(2):127-39. doi: 10.1002/phar.1531. Epub 2015 Feb 3.
5
Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia.老年医院获得性肺炎患者中万古霉素临床疗效与新的药代动力学参数谷浓度下面积(AUTL)的相关性。
J Clin Pharm Ther. 2016 Aug;41(4):399-402. doi: 10.1111/jcpt.12399. Epub 2016 May 4.
6
Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.朝着万古霉素精准剂量给药迈进:贝叶斯预测的药代动力学模型系统评价。
Clin Microbiol Infect. 2019 Oct;25(10):1286.e1-1286.e7. doi: 10.1016/j.cmi.2019.02.029. Epub 2019 Mar 11.
7
Correlation of a Vancomycin Pharmacokinetic Model and Trough Serum Concentrations in Pediatric Patients.万古霉素药代动力学模型与儿科患者血清谷浓度的相关性
Pediatr Infect Dis J. 2015 Oct;34(10):e244-7. doi: 10.1097/INF.0000000000000817.
8
Validation of a pediatric population pharmacokinetic model for vancomycin.万古霉素儿科群体药代动力学模型的验证
Ther Drug Monit. 2015 Jun;37(3):413-6. doi: 10.1097/FTD.0000000000000153.
9
Review and Validation of Bayesian Dose-Optimizing Software and Equations for Calculation of the Vancomycin Area Under the Curve in Critically Ill Patients.贝叶斯剂量优化软件和计算危重症患者万古霉素曲线下面积方程的回顾与验证。
Pharmacotherapy. 2018 Dec;38(12):1174-1183. doi: 10.1002/phar.2191. Epub 2018 Nov 23.
10
Prospective Trial on the Use of Trough Concentration versus Area under the Curve To Determine Therapeutic Vancomycin Dosing.前瞻性研究使用谷浓度与曲线下面积来确定治疗万古霉素剂量。
Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.02042-17. Print 2018 Feb.

引用本文的文献

1
Clinical Practice Guidelines for Therapeutic Drug Monitoring of Vancomycin in the Framework of Model-Informed Precision Dosing: A Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.基于模型的精准给药框架下万古霉素治疗药物监测临床实践指南:日本化疗学会和日本治疗药物监测学会的共识性综述
Pharmaceutics. 2022 Feb 23;14(3):489. doi: 10.3390/pharmaceutics14030489.
2
Why we should sample sparsely and aim for a higher target: Lessons from model-based therapeutic drug monitoring of vancomycin in intensive care patients.为什么我们应该稀疏采样并追求更高的目标:来自重症监护患者万古霉素基于模型的治疗药物监测的经验教训。
Br J Clin Pharmacol. 2021 Mar;87(3):1234-1242. doi: 10.1111/bcp.14498. Epub 2020 Aug 17.
3
Relationships of Vancomycin Pharmacokinetics to Body Size and Composition Using a Novel Pharmacomorphomic Approach Based on Medical Imaging.基于医学影像的新型药效形态学方法研究万古霉素药代动力学与人体大小和组成的关系。
Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.01402-17. Print 2017 Nov.

本文引用的文献

1
Individualized vancomycin dosing in obese patients: a two-sample measurement approach improves target attainment.肥胖患者的个体化万古霉素给药:双样本测量方法可提高目标达成率。
Pharmacotherapy. 2015 May;35(5):455-63. doi: 10.1002/phar.1588.
2
Innovative approaches to optimizing the delivery of vancomycin in individual patients.优化个体化患者万古霉素给药的创新方法。
Adv Drug Deliv Rev. 2014 Nov 20;77:50-7. doi: 10.1016/j.addr.2014.05.016. Epub 2014 Jun 5.
3
Are vancomycin trough concentrations adequate for optimal dosing?万古霉素谷浓度是否足以达到最佳给药剂量?
Antimicrob Agents Chemother. 2014;58(1):309-16. doi: 10.1128/AAC.01653-13. Epub 2013 Oct 28.
4
Vancomycin: a review of population pharmacokinetic analyses.万古霉素:群体药代动力学分析综述。
Clin Pharmacokinet. 2012 Jan 1;51(1):1-13. doi: 10.2165/11596390-000000000-00000.
5
Estimating creatinine clearance: a meta-analysis.估算肌酐清除率:一项荟萃分析。
Pharmacotherapy. 2011 Jul;31(7):658-64. doi: 10.1592/phco.31.7.658.
6
Estimating the glomerular filtration rate in obese adult patients for drug dosing.估算肥胖成年患者的肾小球滤过率以进行药物剂量调整。
Adv Chronic Kidney Dis. 2010 Sep;17(5):e53-62. doi: 10.1053/j.ackd.2010.05.010.
7
Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.成人患者万古霉素的治疗监测:美国卫生系统药师协会、美国传染病学会和传染病药师协会的共识综述
Am J Health Syst Pharm. 2009 Jan 1;66(1):82-98. doi: 10.2146/ajhp080434.
8
Vancomycin dosing in morbidly obese patients.肥胖症患者的万古霉素给药剂量
Eur J Clin Pharmacol. 1998 Oct;54(8):621-5. doi: 10.1007/s002280050524.
9
Vancomycin pharmacokinetics in patients with various degrees of renal function.不同肾功能程度患者的万古霉素药代动力学
Antimicrob Agents Chemother. 1988 Jun;32(6):848-52. doi: 10.1128/AAC.32.6.848.